The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Tissue Regenix Group's share price is £0.62.
Tissue Regenix Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.33. Hence, Tissue Regenix Group's PS Ratio for today is 1.87.
The historical rank and industry rank for Tissue Regenix Group's PS Ratio or its related term are showing as below:
LSE:TRX'
s PS Ratio Range Over the Past 10 Years
Min: 0.28 Med: 12.76 Max: 30750
Current: 1.87
During the past 13 years, Tissue Regenix Group's highest PS Ratio was 30750.00. The lowest was 0.28. And the median was 12.76.
LSE:TRX's PS Ratio is ranked better than 86.7% of 1000
companies
in the Biotechnology industry
Industry Median: 9.305
vs LSE:TRX: 1.87
Tissue Regenix Group PLC revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Tissue Regenix Group was 15.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -24.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 59.70% per year.
During the past 13 years, Tissue Regenix Group's highest 3-Year average Revenue per Share Growth Rate was 730.60% per year. The lowest was -40.30% per year. And the median was 6.20% per year.
Back to Basics: PS Ratio
Tissue Regenix Group PS Ratio Historical Data
The historical data trend for Tissue Regenix Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tissue Regenix Group's PS Ratio
For the Biotechnology subindustry, Tissue Regenix Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tissue Regenix Group's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Tissue Regenix Group's PS Ratio falls into.
Tissue Regenix Group PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Tissue Regenix Group's Share Price of today is £0.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tissue Regenix Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.33.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Tissue Regenix Group (LSE:TRX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Tissue Regenix Group PS Ratio Related Terms
Thank you for viewing the detailed overview of Tissue Regenix Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Tissue Regenix Group (LSE:TRX) Business Description
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:TRX has been successfully added to your 